$0.940
-0.044 (-4.67%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CRDF por análisis de gráficos similares
Alphio's CRDF stock price prediction model matches the current Cardiff Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.93 (-0.81%). The 1-week path is $0.93 (-0.68%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Cardiff Oncology Inc?
Cardiff Oncology Inc is currently priced at $0.94, which is significantly lower than its previous highs and the average analyst target of $4. However, the stock has shown a 6.81% increase over the last five days, suggesting some short-term momentum. The RSI is at 44.76, indicating that the stock is neither overbought nor oversold, which may suggest a hold position. The main risk is the ongoing legal dispute regarding the onvansertib license, which could impact future financing and development, as highlighted by multiple analysts downgrading their ratings due to this uncertainty.
CRDF cerró en $0.94 el Friday, tras bajar -4.67%
Cardiff Oncology Inc (CRDF) last closed at $0.94, losing -4.67%. These facts feed the 1-day and 1-week CRDF price prediction above.
Factores de la previsión
Los factores de la previsión de Cardiff Oncology Inc (CRDF) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CRDF, ordenadas por similitud.
Análisis de estacionalidad de CRDF
Historically the probability of a positive August return for CRDF is 34.92%. February offers the highest probability of a positive month at 53.45%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CRDF
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $3.11 | $3.20 | $3.60 | +240.32% |
| Sep 2026 | $3.03 | $3.35 | $3.67 | +256.51% |
| Oct 2026 | $3.30 | $3.35 | $3.56 | +256.51% |
| Nov 2026 | $3.32 | $3.35 | $3.53 | +256.51% |
| Dec 2026 | $2.97 | $3.35 | $3.61 | +256.51% |
En 2026, se proyecta que Cardiff Oncology Inc (CRDF) oscile entre $2.97 y $3.67.
Previsión mensual de Cardiff Oncology Inc para 2026
En Aug de 2026, se proyecta que Cardiff Oncology Inc promedie $3.20, con un mínimo de $3.11 y un máximo de $3.60.
En Sep de 2026, se proyecta que Cardiff Oncology Inc promedie $3.35, con un mínimo de $3.03 y un máximo de $3.67.
En Oct de 2026, se proyecta que Cardiff Oncology Inc promedie $3.35, con un mínimo de $3.30 y un máximo de $3.56.
En Nov de 2026, se proyecta que Cardiff Oncology Inc promedie $3.35, con un mínimo de $3.32 y un máximo de $3.53.
En Dec de 2026, se proyecta que Cardiff Oncology Inc promedie $3.35, con un mínimo de $2.97 y un máximo de $3.61.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.